MedTrace Logo

Bronchial Dilation Test in Wheezy Infants

NCT03467776 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2018-03-16

No results posted yet for this study

Summary

The purpose of the study is to establish the methodology of bronchial dilation test by salbutamol MDI with Spacer in wheezy infants with asthma and to evaluate the effects of atopy on the exacerbation of wheeze in wheezy infants.

Conditions

Sponsors & Collaborators

  • Firestone Institute for Respiratory Health

    collaborator OTHER

  • Guangzhou Institute of Respiratory Disease

    lead OTHER

Principal Investigators

  • jinping Zheng · Guangzhou Institute of Respiratory Disease

Eligibility

Min Age
5 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2019-05-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03467776 on ClinicalTrials.gov